Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LB1908 |
Synonyms | |
Therapy Description |
LB1908 are autologous T-cells engineered to express a chimeric antigen receptor (CAR) targeting Claudin 18.2 (CLDN18.2), which potentially induce toxicity in tumor cells expressing CLDN18.2 (NCI Drug Dictionary). |